Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Buserelin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR known ✓ | P30968 | 2/20 | 0.75 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.75 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.69 |
| ▸ | APLNR | P35414 | 4/20 | 0.58 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Buserelin SCHEMBL2544038 | 0.99 | ABCC2 (0.76) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Goserelin SCHEMBL5605264 | 0.98 | GNRHR (0.73) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Goserelin SCHEMBL4735617 | 0.98 | ABCC2 (0.74) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Goserelin SCHEMBL7202372 | 0.98 | ABCC2 (0.74) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Buserelin SCHEMBL15214196 | 0.97 | GNRHR (0.80) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Buserelin SCHEMBL29598917 | 0.97 | GNRHR (0.80) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Buserelin SCHEMBL14193133 | 0.96 | GNRHR (0.68) | GNRHRABCC2PTGS1APLNR | |
| Buserelin SCHEMBL16766450 | 0.96 | GNRHR (0.68) | GNRHRABCC2PTGS1APLNR | |
| Buserelin SCHEMBL29833854 | 0.96 | GNRHR (0.68) | GNRHRABCC2PTGS1APLNR | |
| Buserelin SCHEMBL13354 | 0.96 | GNRHR (0.68) | GNRHRABCC2PTGS1APLNR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2246063-A1 | Sustained release formulations comprising GnRH analogues | IPSEN PHARMA S.A.S. (FR) | 2010-11-03 | — | — | EP | disclosed |